Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study

Abstract Background Dementia is an increasing public health threat worldwide. The pathogenesis of dementia has not been fully elucidated yet. Inflammatory processes are hypothesized to play an important role as a driver for cognitive decline but the origin of inflammation is not clear. We hypothesiz...

Full description

Bibliographic Details
Main Authors: Vanessa Stadlbauer, Lara Engertsberger, Irina Komarova, Nicole Feldbacher, Bettina Leber, Gerald Pichler, Nicole Fink, Monika Scarpatetti, Walter Schippinger, Reinhold Schmidt, Angela Horvath
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Geriatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12877-020-01644-2
_version_ 1819020509132619776
author Vanessa Stadlbauer
Lara Engertsberger
Irina Komarova
Nicole Feldbacher
Bettina Leber
Gerald Pichler
Nicole Fink
Monika Scarpatetti
Walter Schippinger
Reinhold Schmidt
Angela Horvath
author_facet Vanessa Stadlbauer
Lara Engertsberger
Irina Komarova
Nicole Feldbacher
Bettina Leber
Gerald Pichler
Nicole Fink
Monika Scarpatetti
Walter Schippinger
Reinhold Schmidt
Angela Horvath
author_sort Vanessa Stadlbauer
collection DOAJ
description Abstract Background Dementia is an increasing public health threat worldwide. The pathogenesis of dementia has not been fully elucidated yet. Inflammatory processes are hypothesized to play an important role as a driver for cognitive decline but the origin of inflammation is not clear. We hypothesize that disturbances in gut microbiome composition, gut barrier dysfunction, bacterial translocation and resulting inflammation are associated with cognitive dysfunction in dementia. Methods To test this hypothesis, a cohort of 23 patients with dementia and 18 age and sex matched controls without cognitive impairments were studied. Gut microbiome composition, gut barrier dysfunction, bacterial translocation and inflammation were assessed from stool and serum samples. Malnutrition was assessed by Mini Nutritional Assessment Short Form (MNA-SF), detailed information on drug use was collected. Microbiome composition was assessed by 16S rRNA sequencing, QIIME 2 and Calypso 7.14 tools. Results Dementia was associated with dysbiosis characterized by differences in beta diversity and changes in taxonomic composition. Gut permeability was increased as evidenced by increased serum diamine oxidase (DAO) levels and systemic inflammation was confirmed by increased soluble cluster of differentiation 14 levels (sCD14). BMI and statin use had the strongest impact on microbiome composition. Conclusion Dementia is associated with changes in gut microbiome composition and increased biomarkers of gut permeability and inflammation. Lachnospiraceae NK4A136 group as potential butyrate producer was reduced in dementia. Malnutrition and drug intake were factors, that impact on microbiome composition. Increasing butyrate producing bacteria and targeting malnutrition may be promising therapeutic targets in dementia. Trial registration NCT03167983 .
first_indexed 2024-12-21T03:52:20Z
format Article
id doaj.art-04a3c2f9852d4a54a5e67cb54a379cd2
institution Directory Open Access Journal
issn 1471-2318
language English
last_indexed 2024-12-21T03:52:20Z
publishDate 2020-07-01
publisher BMC
record_format Article
series BMC Geriatrics
spelling doaj.art-04a3c2f9852d4a54a5e67cb54a379cd22022-12-21T19:16:55ZengBMCBMC Geriatrics1471-23182020-07-0120111310.1186/s12877-020-01644-2Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot studyVanessa Stadlbauer0Lara Engertsberger1Irina Komarova2Nicole Feldbacher3Bettina Leber4Gerald Pichler5Nicole Fink6Monika Scarpatetti7Walter Schippinger8Reinhold Schmidt9Angela Horvath10Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of GrazDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of GrazDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of GrazDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of GrazDepartment of Surgery, Division of Transplantation Surgery, Medical University of GrazDepartment of Neurology, Geriatric Health Centers Graz, Albert Schweitzer HospitalDepartment of Neurology, Geriatric Health Centers Graz, Albert Schweitzer HospitalDepartment of Neurology, Geriatric Health Centers Graz, Albert Schweitzer HospitalDepartment of Neurology, Geriatric Health Centers Graz, Albert Schweitzer HospitalClinical Division of Neurogeriatrics, Department of Neurology, Medical University of GrazDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of GrazAbstract Background Dementia is an increasing public health threat worldwide. The pathogenesis of dementia has not been fully elucidated yet. Inflammatory processes are hypothesized to play an important role as a driver for cognitive decline but the origin of inflammation is not clear. We hypothesize that disturbances in gut microbiome composition, gut barrier dysfunction, bacterial translocation and resulting inflammation are associated with cognitive dysfunction in dementia. Methods To test this hypothesis, a cohort of 23 patients with dementia and 18 age and sex matched controls without cognitive impairments were studied. Gut microbiome composition, gut barrier dysfunction, bacterial translocation and inflammation were assessed from stool and serum samples. Malnutrition was assessed by Mini Nutritional Assessment Short Form (MNA-SF), detailed information on drug use was collected. Microbiome composition was assessed by 16S rRNA sequencing, QIIME 2 and Calypso 7.14 tools. Results Dementia was associated with dysbiosis characterized by differences in beta diversity and changes in taxonomic composition. Gut permeability was increased as evidenced by increased serum diamine oxidase (DAO) levels and systemic inflammation was confirmed by increased soluble cluster of differentiation 14 levels (sCD14). BMI and statin use had the strongest impact on microbiome composition. Conclusion Dementia is associated with changes in gut microbiome composition and increased biomarkers of gut permeability and inflammation. Lachnospiraceae NK4A136 group as potential butyrate producer was reduced in dementia. Malnutrition and drug intake were factors, that impact on microbiome composition. Increasing butyrate producing bacteria and targeting malnutrition may be promising therapeutic targets in dementia. Trial registration NCT03167983 .http://link.springer.com/article/10.1186/s12877-020-01644-2MicrobiomeDiversityGut barrierInflammationCognitive functionButyrate producer
spellingShingle Vanessa Stadlbauer
Lara Engertsberger
Irina Komarova
Nicole Feldbacher
Bettina Leber
Gerald Pichler
Nicole Fink
Monika Scarpatetti
Walter Schippinger
Reinhold Schmidt
Angela Horvath
Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
BMC Geriatrics
Microbiome
Diversity
Gut barrier
Inflammation
Cognitive function
Butyrate producer
title Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
title_full Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
title_fullStr Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
title_full_unstemmed Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
title_short Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
title_sort dysbiosis gut barrier dysfunction and inflammation in dementia a pilot study
topic Microbiome
Diversity
Gut barrier
Inflammation
Cognitive function
Butyrate producer
url http://link.springer.com/article/10.1186/s12877-020-01644-2
work_keys_str_mv AT vanessastadlbauer dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT laraengertsberger dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT irinakomarova dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT nicolefeldbacher dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT bettinaleber dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT geraldpichler dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT nicolefink dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT monikascarpatetti dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT walterschippinger dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT reinholdschmidt dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy
AT angelahorvath dysbiosisgutbarrierdysfunctionandinflammationindementiaapilotstudy